The shift is changing gears. The pharmaceutical companies which have been outsourcing drug manufacturing to Asian countries are now moving one level up to clinical trials.
There is a trend towards a changed business model in the pharma sector and major pharmaceutical companies are now starting to focus their attention on outsourcing more clinical research rather than manufacturing operations, according to a new report from Pricewaterhouse Coopers.
Why this change of trend. Firstly, it seems obvious, when clients become comfortable dealing with outsourcing companies they start expecting more from them and thus happens going up in value chain. Secondly, as always market dynamics play a big role in this. In India’s case it was the country’s “effort to be compliant with international intellectual property (IP) laws two years ago, but also India's recent resolution to recognize product patents.” For China, it’s the availability of highly skilled low cost workforce that have attracted pharma biggies setting up their stations there.
Comment Preview